Biomarkers May Predict Omalizumab Response in Urticaria

In patients with chronic spontaneous urticaria, biomarkers such as a positive chronic urticaria index and low blood histamine content may help predict poor response to omalizumab at 12 weeks.
Medscape Medical News

source https://www.medscape.com/viewarticle/biomarkers-may-predict-omalizumab-response-urticaria-2025a1000y8c?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension